Stoke Therapeutics, Inc.
STOK
$9.76
-$0.12-1.22%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 216.90M | 239.20M | 281.98M | 178.58M | 201.39M |
Total Receivables | 700.00K | 691.00K | 305.00K | 11.00K | 64.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 11.12M | 9.84M | 10.35M | 10.72M | 11.32M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 4.04M | 3.88M | 4.36M | 3.96M | 2.56M |
Total Current Assets | 232.76M | 253.61M | 296.99M | 193.28M | 215.34M |
|
|||||
Total Current Assets | 232.76M | 253.61M | 296.99M | 193.28M | 215.34M |
Net Property, Plant & Equipment | 8.25M | 9.26M | 10.27M | 11.34M | 12.43M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 721.00K | 494.00K | 494.00K | 569.00K | 569.00K |
Total Assets | 271.56M | 293.32M | 307.76M | 205.18M | 228.34M |
|
|||||
Total Accounts Payable | 2.50M | 2.49M | 3.95M | 2.10M | 1.70M |
Total Accrued Expenses | 15.49M | 12.87M | 11.19M | 9.38M | 10.90M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.32M | 2.30M | 2.28M | 2.21M | 2.06M |
Total Finance Division Other Current Liabilities | 19.74M | 32.21M | 27.09M | 21.90M | 16.17M |
Total Other Current Liabilities | 19.74M | 32.21M | 27.09M | 21.90M | 16.17M |
Total Current Liabilities | 40.06M | 49.87M | 44.50M | 35.59M | 30.82M |
|
|||||
Total Current Liabilities | 40.06M | 49.87M | 44.50M | 35.59M | 30.82M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 2.45M | 3.01M | 3.55M | 4.13M | 4.77M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 26.00K | 8.33M | 17.00M | 25.13M | 33.19M |
Total Liabilities | 42.53M | 61.21M | 65.05M | 64.84M | 68.78M |
|
|||||
Common Stock & APIC | 720.00M | 712.30M | 696.64M | 568.57M | 561.44M |
Retained Earnings | -490.83M | -480.35M | -453.92M | -428.22M | -401.85M |
Treasury Stock & Other | -151.00K | 166.00K | -15.00K | -- | -24.00K |
Total Common Equity | 229.02M | 232.11M | 242.71M | 140.34M | 159.57M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 229.02M | 232.11M | 242.71M | 140.34M | 159.57M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 229.02M | 232.11M | 242.71M | 140.34M | 159.57M |
|